Ziegler, Verena <br/><br/>
Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.  [electronic resource] 

 -  Biochimica et biophysica acta  Jun 2016 
 - 1082-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3002 
<br/><br/><label>Standard No.: </label>10.1016/j.bbamcr.2016.02.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibiotics, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins--metabolism<br/>Blotting, Western<br/>Cell Cycle--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Checkpoint Kinase 1<br/>DNA Damage--drug effects<br/>Dose-Response Relationship, Drug<br/>Dose-Response Relationship, Radiation<br/>Doxorubicin--pharmacology<br/>Enzyme Activation--drug effects<br/>Histones--metabolism<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Keratinocytes--drug effects<br/>Lovastatin--pharmacology<br/>Protein Kinases--metabolism<br/>Radiation, Ionizing<br/>Time Factors